Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue

Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue Byung-Soo Youn 1 , Sa-Ik Bang 2 , Nora Klöting 3 , Ji Woo Park 1 , Namseok Lee 1 , Ji-Eun Oh 1 , Kyung-Bae Pi 1 , Tae Hee Lee 4 , Karen Ruschke 3 , Mathias Fasshauer 3 , Michael Stumvoll 3 and...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 58; no. 3; pp. 627 - 636
Main Authors Youn, Byung-Soo, Bang, Sa-Ik, Klöting, Nora, Park, Ji Woo, Lee, Namseok, Oh, Ji-Eun, Pi, Kyung-Bae, Lee, Tae Hee, Ruschke, Karen, Fasshauer, Mathias, Stumvoll, Michael, Blüher, Matthias
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.03.2009
Subjects
Online AccessGet full text
ISSN0012-1797
1939-327X
1939-327X
DOI10.2337/db08-1147

Cover

Loading…
Abstract Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue Byung-Soo Youn 1 , Sa-Ik Bang 2 , Nora Klöting 3 , Ji Woo Park 1 , Namseok Lee 1 , Ji-Eun Oh 1 , Kyung-Bae Pi 1 , Tae Hee Lee 4 , Karen Ruschke 3 , Mathias Fasshauer 3 , Michael Stumvoll 3 and Matthias Blüher 3 1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea 2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 3 Department of Medicine, University of Leipzig, Leipzig, Germany 4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea Corresponding authors: Matthias Blüher, bluma{at}medizin.uni-leipzig.de , and Byung-Soo Youn, bsyoun{at}adipogen.com Abstract OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS— For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays. RESULTS— Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS— Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 3 December 2008. B.-S.Y. and S.-I.B. contributed equally to this study. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted November 19, 2008. Received August 22, 2008. DIABETES
AbstractList OBJECTIVE—Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS—For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays. RESULTS—Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS—Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.
Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue Byung-Soo Youn 1 , Sa-Ik Bang 2 , Nora Klöting 3 , Ji Woo Park 1 , Namseok Lee 1 , Ji-Eun Oh 1 , Kyung-Bae Pi 1 , Tae Hee Lee 4 , Karen Ruschke 3 , Mathias Fasshauer 3 , Michael Stumvoll 3 and Matthias Blüher 3 1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea 2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 3 Department of Medicine, University of Leipzig, Leipzig, Germany 4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea Corresponding authors: Matthias Blüher, bluma{at}medizin.uni-leipzig.de , and Byung-Soo Youn, bsyoun{at}adipogen.com Abstract OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS— For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays. RESULTS— Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS— Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 3 December 2008. B.-S.Y. and S.-I.B. contributed equally to this study. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted November 19, 2008. Received August 22, 2008. DIABETES
Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown.OBJECTIVEProgranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown.For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays.RESEARCH DESIGN AND METHODSFor the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays.Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels.RESULTSProgranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels.Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.CONCLUSIONSElevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.
OBJECTIVE--Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS--For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-l-based cell migration assays. RESULTS--Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS--Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Diabetes 58:627-636, 2009
Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays. Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.
Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays. Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.
OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS— For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays. RESULTS— Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS— Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.
Audience Professional
Author Ji Woo Park
Tae Hee Lee
Nora Klöting
Kyung-Bae Pi
Byung-Soo Youn
Ji-Eun Oh
Sa-Ik Bang
Mathias Fasshauer
Namseok Lee
Matthias Blüher
Karen Ruschke
Michael Stumvoll
AuthorAffiliation 3 Department of Medicine, University of Leipzig, Leipzig, Germany
2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea
AuthorAffiliation_xml – name: 3 Department of Medicine, University of Leipzig, Leipzig, Germany
– name: 4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea
– name: 2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– name: 1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
Author_xml – sequence: 1
  givenname: Byung-Soo
  surname: Youn
  fullname: Youn, Byung-Soo
  organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
– sequence: 2
  givenname: Sa-Ik
  surname: Bang
  fullname: Bang, Sa-Ik
  organization: Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
– sequence: 3
  givenname: Nora
  surname: Klöting
  fullname: Klöting, Nora
  organization: Department of Medicine, University of Leipzig, Leipzig, Germany
– sequence: 4
  givenname: Ji Woo
  surname: Park
  fullname: Park, Ji Woo
  organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
– sequence: 5
  givenname: Namseok
  surname: Lee
  fullname: Lee, Namseok
  organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
– sequence: 6
  givenname: Ji-Eun
  surname: Oh
  fullname: Oh, Ji-Eun
  organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
– sequence: 7
  givenname: Kyung-Bae
  surname: Pi
  fullname: Pi, Kyung-Bae
  organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
– sequence: 8
  givenname: Tae Hee
  surname: Lee
  fullname: Lee, Tae Hee
  organization: Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea
– sequence: 9
  givenname: Karen
  surname: Ruschke
  fullname: Ruschke, Karen
  organization: Department of Medicine, University of Leipzig, Leipzig, Germany
– sequence: 10
  givenname: Mathias
  surname: Fasshauer
  fullname: Fasshauer, Mathias
  organization: Department of Medicine, University of Leipzig, Leipzig, Germany
– sequence: 11
  givenname: Michael
  surname: Stumvoll
  fullname: Stumvoll, Michael
  organization: Department of Medicine, University of Leipzig, Leipzig, Germany
– sequence: 12
  givenname: Matthias
  surname: Blüher
  fullname: Blüher, Matthias
  organization: Department of Medicine, University of Leipzig, Leipzig, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21204963$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19056610$$D View this record in MEDLINE/PubMed
BookMark eNptkl2L1DAUhousuB964R-QIigodDdJ26S9EcZB14WREVzRu5BJTjtZ02RsWnX_vWecccdZhhD6kee8Sd7zniZHPnhIkqeUnLM8FxdmQaqM0kI8SE5onddZzsS3o-SEEMoyKmpxnJzGeEMI4TgeJce0JiXnlJwk3z9DP3bppz60vfKjsz6dBq_BD70abPAx_ahu07eQTmIM2qoBTPrVDkv8rfuwWqoW0ivfWLfl8WMI6bxDAeXSibGrECG9tjGO8Dh52CgX4cn2eZZ8ef_uevohm80vr6aTWaY5LYZsUdOiqpu8MbluGlVy4IwKyo1Zz5IJUEywsqoMAAIV0ELzwqiG4oJpVH6WvNnorsZFB2ZzGSdXve1UfyuDsnJ_xdulbMNPyXiBBlEUeLkV6MOPEeIgOxs1OKc8hDFKzmtREEYQfH4PvAlj7_FyklFeCF5XBULZBmqVA2l9E3BT3YIH3BsbieaBnNC6ZFxgs5A_P8DjMNBZfbDg1V4BMgP8Hlo1xiiry9k-mx1idXAOWpDYh-l8n3_2v5d3Jv5LEAIvtoCKWrkGU6RtvOMYZaSoeb47JMYmxh6anRSR6xTLdYrlOsXIXtxjtR3-xgudsO5gxetNxdK2y1-2B2msWsAAcfdSVjKXnIn8D__FAiA
CODEN DIAEAZ
CitedBy_id crossref_primary_10_1007_s00125_013_3139_y
crossref_primary_10_1093_jnen_nlz022
crossref_primary_10_1371_journal_pone_0099785
crossref_primary_10_1080_15384101_2015_1041686
crossref_primary_10_1111_pedi_12915
crossref_primary_10_1186_1475_2840_13_14
crossref_primary_10_1016_j_ddmec_2013_09_002
crossref_primary_10_1111_nyas_14568
crossref_primary_10_1186_s43044_020_00063_3
crossref_primary_10_1530_JME_15_0075
crossref_primary_10_20945_2359_3997000000022
crossref_primary_10_1152_ajpendo_00297_2015
crossref_primary_10_1002_ehf2_12678
crossref_primary_10_18585_inabj_v5i2_59
crossref_primary_10_1093_gerona_glac018
crossref_primary_10_1080_09513590_2021_1958311
crossref_primary_10_3389_fimmu_2018_02952
crossref_primary_10_1016_j_jcte_2014_07_005
crossref_primary_10_1016_j_ajpath_2010_11_002
crossref_primary_10_1007_s00109_020_01942_7
crossref_primary_10_1371_journal_pone_0039880
crossref_primary_10_1016_j_cytogfr_2023_11_001
crossref_primary_10_1016_j_tem_2013_08_003
crossref_primary_10_1016_j_cyto_2019_154796
crossref_primary_10_3390_ijms25031815
crossref_primary_10_3233_JAD_170747
crossref_primary_10_1136_thoraxjnl_2018_211916
crossref_primary_10_3390_molecules25040775
crossref_primary_10_3109_14767058_2013_853734
crossref_primary_10_1371_journal_pone_0013911
crossref_primary_10_1186_s12920_023_01752_z
crossref_primary_10_1007_s40200_019_00406_1
crossref_primary_10_1007_s11033_013_2804_z
crossref_primary_10_1002_dmrr_1034
crossref_primary_10_1155_2013_803240
crossref_primary_10_1016_j_bcp_2022_115324
crossref_primary_10_1007_s11892_018_1110_5
crossref_primary_10_1007_s11481_013_9495_z
crossref_primary_10_1016_j_diabres_2016_07_017
crossref_primary_10_1371_journal_pone_0055744
crossref_primary_10_3389_fncel_2022_874258
crossref_primary_10_3389_fendo_2022_873699
crossref_primary_10_1007_s40496_018_0177_z
crossref_primary_10_1080_14728222_2018_1487951
crossref_primary_10_1189_jlb_0812429
crossref_primary_10_1007_s00784_014_1308_0
crossref_primary_10_1055_a_2106_6930
crossref_primary_10_1210_en_2011_1221
crossref_primary_10_1515_hmbci_2019_0050
crossref_primary_10_1038_s41467_024_48914_w
crossref_primary_10_2217_bmm_09_82
crossref_primary_10_1016_j_drudis_2014_06_021
crossref_primary_10_1016_j_ejogrb_2017_09_017
crossref_primary_10_1515_jpem_2016_0378
crossref_primary_10_1371_journal_pone_0076679
crossref_primary_10_1530_EJE_12_0060
crossref_primary_10_1210_me_2014_1266
crossref_primary_10_1016_j_cmet_2011_12_002
crossref_primary_10_2337_dc11_1267
crossref_primary_10_1016_j_bbrc_2011_10_060
crossref_primary_10_1007_s12035_012_8380_8
crossref_primary_10_1007_s12031_011_9553_z
crossref_primary_10_1042_CS20160005
crossref_primary_10_1111_eci_12558
crossref_primary_10_1155_2018_1251345
crossref_primary_10_1007_s41972_021_00129_7
crossref_primary_10_1371_journal_pone_0065542
crossref_primary_10_34172_joddd_2020_029
crossref_primary_10_1111_jgs_17604
crossref_primary_10_3389_fcell_2022_836196
crossref_primary_10_1002_trc2_12452
crossref_primary_10_1038_srep20356
crossref_primary_10_1074_jbc_M112_441949
crossref_primary_10_1093_cvr_cvt178
crossref_primary_10_1371_journal_pone_0239061
crossref_primary_10_1507_endocrj_EJ14_0210
crossref_primary_10_1002_jcp_25855
crossref_primary_10_1371_journal_pone_0192959
crossref_primary_10_1155_2015_740357
crossref_primary_10_15407_ubj85_03_010
crossref_primary_10_1016_j_cca_2019_07_006
crossref_primary_10_1515_jpem_2017_0321
crossref_primary_10_1080_21655979_2019_1607126
crossref_primary_10_3389_fphys_2020_578966
crossref_primary_10_1002_dneu_22499
crossref_primary_10_3390_biology10050400
crossref_primary_10_1016_j_soard_2020_06_056
crossref_primary_10_1016_j_crneur_2023_100094
crossref_primary_10_1080_13543784_2024_2349286
crossref_primary_10_3390_medicina60071165
crossref_primary_10_1507_endocrj_EJ20_0037
crossref_primary_10_3389_fnmol_2021_713031
crossref_primary_10_4103_tjd_tjd_67_21
crossref_primary_10_1016_j_metabol_2014_10_016
crossref_primary_10_1155_2015_357279
crossref_primary_10_2337_dc12_0220
crossref_primary_10_1210_en_2014_1058
crossref_primary_10_1159_000448896
crossref_primary_10_2217_clp_09_86
crossref_primary_10_1371_journal_pone_0238877
crossref_primary_10_4093_dmj_2012_36_5_317
crossref_primary_10_3390_metabo15030169
crossref_primary_10_1016_j_biopha_2023_114847
crossref_primary_10_1152_ajpendo_00586_2009
crossref_primary_10_1007_s00401_009_0616_y
crossref_primary_10_1371_journal_pone_0165177
crossref_primary_10_1074_jbc_RA119_011164
crossref_primary_10_1111_nyas_14905
crossref_primary_10_1016_j_ejps_2022_106215
crossref_primary_10_1016_j_soard_2020_09_007
crossref_primary_10_1515_rjim_2016_0034
crossref_primary_10_1186_s12974_021_02203_1
crossref_primary_10_1007_s12031_011_9569_4
crossref_primary_10_1093_hmg_ddx413
crossref_primary_10_3390_nu13114125
crossref_primary_10_3892_etm_2021_10772
crossref_primary_10_1164_rccm_201601_0056OC
crossref_primary_10_1007_s00404_014_3296_3
crossref_primary_10_1016_j_bbrc_2010_08_049
crossref_primary_10_1155_2013_360190
crossref_primary_10_1155_2018_3729402
crossref_primary_10_2147_BCTT_S406685
crossref_primary_10_1210_en_2018_00842
crossref_primary_10_1016_j_jns_2010_10_009
crossref_primary_10_1111_cen_14040
crossref_primary_10_1186_s13098_015_0112_6
crossref_primary_10_3389_fendo_2022_849457
crossref_primary_10_1186_s12950_023_00327_0
crossref_primary_10_4274_MMJ_galenos_2022_10270
crossref_primary_10_1016_j_tips_2015_04_014
crossref_primary_10_1016_j_cyto_2016_08_007
crossref_primary_10_1167_tvst_13_7_9
crossref_primary_10_1080_19420862_2015_1118596
crossref_primary_10_1093_gerona_glaa284
crossref_primary_10_2478_rjdnmd_2013_0022
Cites_doi 10.1093/brain/awn012
10.1080/08977190701781222
10.1016/j.cmet.2007.06.002
10.1016/0026-0495(87)90063-1
10.1016/S0939-4753(04)80048-6
10.1016/S0140-6736(05)66378-7
10.1007/s00125-008-0928-9
10.1016/S0006-291X(03)01452-9
10.1210/jc.2004-1696
10.1210/jc.2006-1811
10.1002/humu.20651
10.1158/0008-5472.CAN-03-2364
10.1038/nature05485
10.2337/diabetes.54.8.2277
10.1038/nature05016
10.1210/edrv.21.6.0415
10.1016/j.bbrc.2006.01.012
10.1172/JCI26498
10.1073/pnas.0601752103
10.1110/ps.073295308
10.1042/bst0290072
10.1038/nm816
10.1007/s00109-003-0474-3
10.1089/met.2004.2.82
10.1152/physrev.90100.2007
10.1172/JCI200319246
10.2337/db06-0133
10.1074/jbc.M601284200
10.1017/S0007114500000982
10.1530/eje.1.02127
10.1038/nature05017
10.1111/j.1471-4159.2007.04968.x
10.1038/sj.ijo.0803632
10.1007/s00125-001-0723-3
ContentType Journal Article
Copyright 2009 INIST-CNRS
COPYRIGHT 2009 American Diabetes Association
Copyright American Diabetes Association Mar 2009
Copyright © 2009, American Diabetes Association
Copyright_xml – notice: 2009 INIST-CNRS
– notice: COPYRIGHT 2009 American Diabetes Association
– notice: Copyright American Diabetes Association Mar 2009
– notice: Copyright © 2009, American Diabetes Association
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
8GL
3V.
7RV
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M1P
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
5PM
DOI 10.2337/db08-1147
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: High School
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni)
Medical Database
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic

Research Library Prep

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 636
ExternalDocumentID PMC2646061
1669437401
A195267179
19056610
21204963
10_2337_db08_1147
diabetes_58_3_627
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations South Korea
GeographicLocations_xml – name: South Korea
GroupedDBID -
08R
0R
1AW
29F
2WC
3V.
4.4
53G
55
5GY
5RE
5RS
5VS
7RV
7X7
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAQQT
AAWTL
AAYEP
AAYJJ
ABFLS
ABOCM
ABPTK
ABUWG
ACDCL
ACGOD
ACPRK
ADACO
ADBBV
ADBIT
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBAFP
BBNVY
BCR
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EX3
F5P
FRP
FYUFA
GICCO
GJ
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
H~9
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
K-O
K9-
KM
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5
M7P
MBDVC
O0-
O5R
O5S
O9-
OB3
OBH
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
WH7
WOQ
WOW
X7M
XZ
ZA5
ZY1
---
.55
.GJ
.XZ
08P
0R~
18M
354
6PF
AAFWJ
AAKAS
AAYOK
AAYXX
ACGFO
ADGHP
ADZCM
AEGXH
AERZD
AIAGR
AIZAD
ALIPV
BTFSW
CCPQU
CITATION
EMOBN
HMCUK
HZ~
ITC
K2M
M5~
N4W
NAPCQ
OHH
PHGZM
PHGZT
TEORI
TR2
UKHRP
VVN
W8F
YFH
YHG
YOC
~KM
1CY
8F7
AFFNX
AI.
IQODW
J5H
MVM
PJZUB
PPXIY
PQGLB
VH1
XOL
YQJ
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
K9.
PKEHL
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c614t-b91489f3fd3cffa56e621716dd16dd527ea272588deecff8e14c64daf1ea2dfa3
IEDL.DBID 7X7
ISSN 0012-1797
1939-327X
IngestDate Thu Aug 21 14:07:41 EDT 2025
Fri Sep 05 03:37:24 EDT 2025
Fri Jul 25 19:33:35 EDT 2025
Fri Jun 13 00:46:53 EDT 2025
Tue Jun 10 21:31:04 EDT 2025
Fri Jun 27 05:33:29 EDT 2025
Tue Jun 10 20:05:56 EDT 2025
Thu Apr 03 06:58:12 EDT 2025
Mon Jul 21 09:15:33 EDT 2025
Tue Jul 01 03:04:00 EDT 2025
Thu Apr 24 23:10:17 EDT 2025
Fri Jan 15 19:45:50 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Endocrinopathy
Serum
Adipose tissue
Diabetes mellitus
Macrophage
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c614t-b91489f3fd3cffa56e621716dd16dd527ea272588deecff8e14c64daf1ea2dfa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Published ahead of print at http://diabetes.diabetesjournals.org on 3 December 2008.
Corresponding authors: Matthias Blüher, bluma@medizin.uni-leipzig.de, and Byung-Soo Youn, bsyoun@adipogen.com
B.-S.Y. and S.-I.B. contributed equally to this study.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC2646061
PMID 19056610
PQID 216476984
PQPubID 34443
PageCount 10
ParticipantIDs pascalfrancis_primary_21204963
pubmed_primary_19056610
proquest_journals_216476984
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2646061
gale_infotracacademiconefile_A195267179
crossref_citationtrail_10_2337_db08_1147
gale_infotracgeneralonefile_A195267179
gale_incontextgauss_8GL_A195267179
crossref_primary_10_2337_db08_1147
highwire_diabetes_diabetes_58_3_627
gale_incontextcollege_GICCO_A195267179
proquest_miscellaneous_66974020
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-03-01
PublicationDateYYYYMMDD 2009-03-01
PublicationDate_xml – month: 03
  year: 2009
  text: 2009-03-01
  day: 01
PublicationDecade 2000
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2009
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References 2022031208305031500_R20
2022031208305031500_R21
2022031208305031500_R22
2022031208305031500_R23
2022031208305031500_R24
2022031208305031500_R25
2022031208305031500_R26
2022031208305031500_R27
2022031208305031500_R28
2022031208305031500_R29
2022031208305031500_R6
2022031208305031500_R19
2022031208305031500_R7
2022031208305031500_R4
2022031208305031500_R5
2022031208305031500_R2
2022031208305031500_R3
2022031208305031500_R1
2022031208305031500_R30
2022031208305031500_R31
2022031208305031500_R10
2022031208305031500_R32
2022031208305031500_R11
2022031208305031500_R33
2022031208305031500_R12
2022031208305031500_R34
2022031208305031500_R13
2022031208305031500_R35
2022031208305031500_R14
2022031208305031500_R15
2022031208305031500_R16
2022031208305031500_R8
2022031208305031500_R17
2022031208305031500_R9
2022031208305031500_R18
12928786 - J Mol Med (Berl). 2003 Oct;81(10):600-12
12017675 - Diabetes Care. 2000 Jan;23 Suppl 1:S4-19
17593905 - Int J Obes (Lond). 2007 Sep;31(9):1420-8
16862116 - Nature. 2006 Aug 24;442(7105):916-9
18251005 - Diabetologia. 2008 Apr;51(4):641-7
18157829 - Hum Mutat. 2008 Jan;29(1):53-8
16046292 - Diabetes. 2005 Aug;54(8):2277-86
10889795 - Br J Nutr. 2000 Mar;83 Suppl 1:S71-7
16731817 - Diabetes. 2006 Jun;55(6):1554-61
17374712 - J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7
14996734 - Cancer Res. 2004 Mar 1;64(5):1737-43
16556721 - Eur J Endocrinol. 2006 Apr;154(4):577-85
18359860 - Protein Sci. 2008 Apr;17(4):711-24
18245784 - Brain. 2008 Mar;131(Pt 3):732-46
12524533 - Nat Med. 2003 Feb;9(2):225-9
18370640 - Metab Syndr Relat Disord. 2004 Jun;2(2):82-104
11133069 - Endocr Rev. 2000 Dec;21(6):697-738
3796297 - Metabolism. 1987 Jan;36(1):54-9
14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
17953663 - J Neurochem. 2008 Jan;104(2):287-97
16427608 - Biochem Biophys Res Commun. 2006 Mar 10;341(2):507-14
17618858 - Cell Metab. 2007 Jul;6(1):79-87
11935152 - Diabetologia. 2002 Feb;45(2):210-6
18092235 - Growth Factors. 2007 Aug;25(4):280-5
16862115 - Nature. 2006 Aug 24;442(7105):920-4
15836891 - Lancet. 2005 Apr 16-22;365(9468):1415-28
15673055 - Nutr Metab Cardiovasc Dis. 2004 Oct;14(5):228-32
16617105 - Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81
18923185 - Physiol Rev. 2008 Oct;88(4):1379-406
15671098 - J Clin Endocrinol Metab. 2005 Apr;90(4):2282-9
11356130 - Biochem Soc Trans. 2001 May;29(Pt 2):72-5
16691291 - J Clin Invest. 2006 Jun;116(6):1494-505
12914763 - Biochem Biophys Res Commun. 2003 Aug 29;308(3):409-13
16809344 - J Biol Chem. 2006 Sep 8;281(36):26602-14
17167474 - Nature. 2006 Dec 14;444(7121):860-7
References_xml – ident: 2022031208305031500_R7
  doi: 10.1093/brain/awn012
– ident: 2022031208305031500_R14
  doi: 10.1080/08977190701781222
– ident: 2022031208305031500_R25
  doi: 10.1016/j.cmet.2007.06.002
– ident: 2022031208305031500_R22
– ident: 2022031208305031500_R23
  doi: 10.1016/0026-0495(87)90063-1
– ident: 2022031208305031500_R5
  doi: 10.1016/S0939-4753(04)80048-6
– ident: 2022031208305031500_R3
  doi: 10.1016/S0140-6736(05)66378-7
– ident: 2022031208305031500_R20
  doi: 10.1007/s00125-008-0928-9
– ident: 2022031208305031500_R11
  doi: 10.1016/S0006-291X(03)01452-9
– ident: 2022031208305031500_R35
  doi: 10.1210/jc.2004-1696
– ident: 2022031208305031500_R18
  doi: 10.1210/jc.2006-1811
– ident: 2022031208305031500_R8
  doi: 10.1002/humu.20651
– ident: 2022031208305031500_R10
  doi: 10.1158/0008-5472.CAN-03-2364
– ident: 2022031208305031500_R1
  doi: 10.1038/nature05485
– ident: 2022031208305031500_R16
  doi: 10.2337/diabetes.54.8.2277
– ident: 2022031208305031500_R28
  doi: 10.1038/nature05016
– ident: 2022031208305031500_R27
  doi: 10.1210/edrv.21.6.0415
– ident: 2022031208305031500_R33
  doi: 10.1016/j.bbrc.2006.01.012
– ident: 2022031208305031500_R34
  doi: 10.1172/JCI26498
– ident: 2022031208305031500_R21
  doi: 10.1073/pnas.0601752103
– ident: 2022031208305031500_R6
  doi: 10.1110/ps.073295308
– ident: 2022031208305031500_R15
  doi: 10.1042/bst0290072
– ident: 2022031208305031500_R12
  doi: 10.1038/nm816
– ident: 2022031208305031500_R13
  doi: 10.1007/s00109-003-0474-3
– ident: 2022031208305031500_R2
  doi: 10.1089/met.2004.2.82
– ident: 2022031208305031500_R30
  doi: 10.1152/physrev.90100.2007
– ident: 2022031208305031500_R31
  doi: 10.1172/JCI200319246
– ident: 2022031208305031500_R17
  doi: 10.2337/db06-0133
– ident: 2022031208305031500_R19
  doi: 10.1074/jbc.M601284200
– ident: 2022031208305031500_R26
  doi: 10.1017/S0007114500000982
– ident: 2022031208305031500_R4
  doi: 10.1530/eje.1.02127
– ident: 2022031208305031500_R29
  doi: 10.1038/nature05017
– ident: 2022031208305031500_R9
  doi: 10.1111/j.1471-4159.2007.04968.x
– ident: 2022031208305031500_R32
  doi: 10.1038/sj.ijo.0803632
– ident: 2022031208305031500_R24
  doi: 10.1007/s00125-001-0723-3
– reference: 18359860 - Protein Sci. 2008 Apr;17(4):711-24
– reference: 16556721 - Eur J Endocrinol. 2006 Apr;154(4):577-85
– reference: 15673055 - Nutr Metab Cardiovasc Dis. 2004 Oct;14(5):228-32
– reference: 3796297 - Metabolism. 1987 Jan;36(1):54-9
– reference: 16617105 - Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81
– reference: 10889795 - Br J Nutr. 2000 Mar;83 Suppl 1:S71-7
– reference: 12017675 - Diabetes Care. 2000 Jan;23 Suppl 1:S4-19
– reference: 16427608 - Biochem Biophys Res Commun. 2006 Mar 10;341(2):507-14
– reference: 12914763 - Biochem Biophys Res Commun. 2003 Aug 29;308(3):409-13
– reference: 16809344 - J Biol Chem. 2006 Sep 8;281(36):26602-14
– reference: 18251005 - Diabetologia. 2008 Apr;51(4):641-7
– reference: 16691291 - J Clin Invest. 2006 Jun;116(6):1494-505
– reference: 18245784 - Brain. 2008 Mar;131(Pt 3):732-46
– reference: 11356130 - Biochem Soc Trans. 2001 May;29(Pt 2):72-5
– reference: 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
– reference: 18923185 - Physiol Rev. 2008 Oct;88(4):1379-406
– reference: 16731817 - Diabetes. 2006 Jun;55(6):1554-61
– reference: 11133069 - Endocr Rev. 2000 Dec;21(6):697-738
– reference: 18092235 - Growth Factors. 2007 Aug;25(4):280-5
– reference: 16046292 - Diabetes. 2005 Aug;54(8):2277-86
– reference: 12928786 - J Mol Med (Berl). 2003 Oct;81(10):600-12
– reference: 17593905 - Int J Obes (Lond). 2007 Sep;31(9):1420-8
– reference: 15671098 - J Clin Endocrinol Metab. 2005 Apr;90(4):2282-9
– reference: 14996734 - Cancer Res. 2004 Mar 1;64(5):1737-43
– reference: 18157829 - Hum Mutat. 2008 Jan;29(1):53-8
– reference: 17618858 - Cell Metab. 2007 Jul;6(1):79-87
– reference: 12524533 - Nat Med. 2003 Feb;9(2):225-9
– reference: 16862116 - Nature. 2006 Aug 24;442(7105):916-9
– reference: 17167474 - Nature. 2006 Dec 14;444(7121):860-7
– reference: 17953663 - J Neurochem. 2008 Jan;104(2):287-97
– reference: 17374712 - J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7
– reference: 15836891 - Lancet. 2005 Apr 16-22;365(9468):1415-28
– reference: 18370640 - Metab Syndr Relat Disord. 2004 Jun;2(2):82-104
– reference: 16862115 - Nature. 2006 Aug 24;442(7105):920-4
– reference: 11935152 - Diabetologia. 2002 Feb;45(2):210-6
SSID ssj0006060
Score 2.358516
Snippet Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue Byung-Soo Youn 1 , Sa-Ik Bang 2 , Nora Klöting 3 ,...
OBJECTIVE—Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated...
Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances;...
OBJECTIVE--Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated...
OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 627
SubjectTerms Adiponectin - blood
Adipose Tissue - physiopathology
Adult
Biological and medical sciences
Blood pressure
Body fat
Breast cancer
Care and treatment
Cohort Studies
Cross-sectional studies
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - genetics
Diabetes Mellitus, Type 2 - physiopathology
Diabetes. Impaired glucose tolerance
Diagnosis
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Enzyme-linked immunosorbent assay
Enzymes
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Fatty Acids, Nonesterified - blood
Female
Fibroblasts
Genetic aspects
Glucose
Glucose Intolerance - blood
Glucose Intolerance - genetics
Health aspects
Humans
Inflammation
Inflammation - blood
Inflammation - genetics
Insulin resistance
Intercellular Signaling Peptides and Proteins - blood
Intercellular Signaling Peptides and Proteins - genetics
Leptin - blood
Lipids - blood
Macrophages
Macrophages - physiology
Male
Medical sciences
Metabolic disorders
Middle Aged
Obesity
Obesity - blood
Obesity - genetics
Obesity - physiopathology
Obesity Studies
Omentum - physiology
Protein expression
Proteins
Reference Values
Research design
RNA, Messenger - genetics
Tumor necrosis factor-TNF
Type 2 diabetes
Title Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue
URI http://diabetes.diabetesjournals.org/content/58/3/627.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19056610
https://www.proquest.com/docview/216476984
https://www.proquest.com/docview/66974020
https://pubmed.ncbi.nlm.nih.gov/PMC2646061
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxAviO-FQbEADV6iLXY-n1BXbQxEtwltom-W44-1YiSFtA_899zFTragiodWbf1TFfvO5zv7_DtC3h2UCuMMFcbcsDBmpQrRyw-TLFMqKoyOWklPT9OTy_jLLJn53JzGp1V2NrE11LpWuEe-z5D4Ki3y-OPyV4hFo_Bw1VfQuEu2W-YyUOds1sdbB-CbuxsoEUMWzswRCzHOs31dIqtphEVVbi1HnVHumIIxUVI2MFbWFbnY5IX-m0x5a3U6fkgeeLeSjp0ePCJ3TPWY3Jv6g_Mn5AfYhPVPet5mY1WYfU4neGGx8qy5DZ3KP_TQ0E5cRtPvi9UcfsYaX3OwOvRzZRfXHg9fVjU9c5UB6FgvlnVj6EUrxafk8vjoYnIS-joLoQIxrcKygJiosNxqrqyVSWpShiw6WuMrYZmRLGNJnmtjAJAbkG0aa2kjaNBW8mdkq6ors0Oo1TLiukiysmRxCe6HipiWpVIcVkFmo4B86IZbKE9CjrUwrgUEIygZgZLBq9JZQN700KVj3tgE2kOZCWSyqDBVRrntFgH9m5yJMWgFSyFiLeDfhsAruW4akX_6OgC99yBbw1Mp6a8oQN-QJWuA3BsgrxxH-Cbg206bRLebfvMhyQUXKYNujAaK1ncYHAsI4VIekN1O84Q3Mo3op0RAXvetYB3wyEdWpl43Ik0hXoSIICDPnZbeDGUBri_4zgHJBvrbA5B3fNhSLeYt_zj40DC1ohf_faZdct8dvGG63kuytfq9Nq_Af1uVo3aWwns-iUZk-_Do9PzbX3dHSZU
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDem0K54FC5W8fp9QCgNLQlN2gqlordlvY8motgBJ0L9UfxHZrK2W6OIWw-RkuzI2vHMzs7sznxDyKt3mcQ4Q7qBr5kbsEy66OW7YRxL6aVaeUtJjw6j_knw-TQ8XSN_6loYTKusbeLSUKtC4hn5DkPgqyhNgg-zny42jcLL1bqDhtWKA33xGyK28v3gI4j3NWP7e-Ne362aCrgS5jR3sxQCgNT4RvnSGBFGOmIIGaMUfkIWa8FiFiaJ0hoIEg2MRIESxoMBZYQPz71B1gMsaO2Q9d29w-MvjemHaMDWvHgMcT9jC2XEfD_eURniqHrYxuXKBlhvAzU2MaZmihKkY2xbjVV-77_pm1f2w_275E7lyNKu1bx7ZE3n98nNUXVV_4B8Byu0-EGPl_lfOea70x6WSOYVTm9JR-KC7mpaK4hW9Ot0PoG_savYBOwcHeRmel7Rw495QY9sLwLaVdNZUWo6XurNQ3JyLUJ4RDp5kesnhBolPF-lYZxlLMjA4ZEeUyKT0od9lxnPIW_r181lBXuO3TfOOYQ_KBmOksHi7NghLxrSmcX6WEW0jTLjiJ2RY3KOtAc8HPjrHfGul4Ysghg5hae1Cc_Eoix58mnYInpTEZkCZiVFVRQBvCEuV4tyu0V5ZlHJVxG-rLWJ1-f3l1_ChPs8YsDGZkvRGobBlYGgMfIdslFrHq_MWsmbReiQrWYU7BFeMolcF4uSRxFEqBCDOOSx1dLLV5mCsw3eukPilv42BIh03h7Jp5Ml4jl47bC0vKf_ndMWudUfj4Z8ODg82CC37bUfJgs-I535r4V-Dt7jPNus1iwl367bTPwF32eH_w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEG9MoV3xKFys1Lt-HhAKKaGhTdtDK3Jb7H00EcUOOBHqT-PfMeO13RpF3HqIlGQ_Wbue2dmZ3dlvCHm9m0mMM6Trc81cn2XSRS_fDaJISi_RyqskPT4K98_8L5Ngskb-NHdhMK2ysYmVoVaFxD3yHkPiqzCJ_Z6psyJO9oYf5j9dLCCFB61NNQ2rIQf68jdEb-X70R6I-g1jw0-ng323LjDgSujfws0SCAYSw43i0pg0CHXIkD5GKfwELNIpi1gQx0prAMQaBhX6KjUeNCiTcnjuLXI74uBUwVSKJm2stwtxgb394jFkAI0sqRHjPOqpDBlVPSzocm0pbBaEhqUYkzTTEuRkbIGNVR7wv4mc11bG4T1yt3Zpad_q4H2ypvMHZGNcH9o_JN_BHi1_0JMqEyzHzHc6wMuSec3YW9Jxekk_atqoilb062wxhb-xvtgULB4d5WZ2UePhx6Kgx7YqAe2r2bwoNT2tNOgRObsRETwm63mR66eEGpV6XCVBlGXMz8D1kR5TaSYlhxWYGc8h75rXLWRNgI51OC4EBEIoGYGSwWvakUNettC5Zf1YBdpBmQlk0chRIaXd6hEwvsGx6HtJwEKIlhN4Whd4ni7LUsSfDzugtzXIFNArmdbXI2BsyNDVQe50kOeWn3wV8FWjTaLZyb_6EsSCi5DBMLY6itYOGJwaCB9D7pDNRvNEbeBK0U5Hh2y3rWCZ8LgpzXWxLEUYQqwK0YhDnlgtvXqVCbjd4Lc7JOrobwtAzvNuSz6bVtzn4L_D1PKe_bdP22QDjIM4HB0dbJI79vwPswafk_XFr6V-AW7kItuqJiwl327aQvwFP7-Kxg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+progranulin+concentrations+may+be+associated+with+macrophage+infiltration+into+omental+adipose+tissue&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Youn%2C+Byung-Soo&rft.au=Bang%2C+Sa-Ik&rft.au=Kloting%2C+Nora&rft.au=Park%2C+Ji+Woo&rft.date=2009-03-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.volume=58&rft.issue=3&rft.spage=627&rft_id=info:doi/10.2337%2Fdb08-1147&rft.externalDocID=A195267179
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon